Glazer Capital LLC’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Glazer Capital LLC’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,579,685	Closed	-$208M	–	306
2025 Q1	$208M	Buy	+1,579,685	New	+$197M	9.64%	1

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Glazer Capital LLC's ITCI Position: Q2 2025 in Review

Glazer Capital LLC sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 1,579,685 shares — an estimated $208M sold.

Glazer Capital LLC first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $208M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Glazer Capital LLC reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Glazer Capital LLC sold 1,579,685 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $208M.
Glazer Capital LLC first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
Glazer Capital LLC's Intra-Cellular Therapies Inc. position peaked at $208M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Glazer Capital LLC's 13F filing for Q2 2025, filed 14 Aug 2025.